Jack Anders - 11 Nov 2026 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

SEC form
4
Accepted by SEC
13 Nov 2026, 18:00:06 UTC
Prior SEC filing
18 Sep 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Jack Anders filed Form 4 for Revolution Medicines, Inc. (RVMD) on 13 Nov 2026.

Key facts

  • This page summarizes Jack Anders's Form 4 filing for Revolution Medicines, Inc. (RVMD).
  • 15 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 13 Nov 2026, 18:00.

Change

  • Previous filing in this sequence was filed on 18 Sep 2026.
  • Current net transaction value: -$6,724,688.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001800668 Primary reporting owner

Anders Jack

Relationship
Chief Financial Officer

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RVMD transaction

Common Stock

Options Exercise

Transaction value
Shares
+15,900
Change %
+13%
Price
$42.45*
Shares after
135,116
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1
RVMD transaction

Common Stock

Options Exercise

Transaction value
Shares
+19,850
Change %
+15%
Price
$18.56*
Shares after
154,966
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1
RVMD transaction

Common Stock

Sale

Transaction value
-$633,466
Shares
-3,499
Change %
-2.3%
Price
$181.04
Shares after
151,467
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1, F2
RVMD transaction

Common Stock

Sale

Transaction value
-$1,051,752
Shares
-5,776
Change %
-3.8%
Price
$182.09
Shares after
145,691
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1, F3
RVMD transaction

Common Stock

Sale

Transaction value
-$493,750
Shares
-2,700
Change %
-1.9%
Price
$182.87
Shares after
142,991
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1, F4
RVMD transaction

Common Stock

Sale

Transaction value
-$349,647
Shares
-1,900
Change %
-1.3%
Price
$184.02
Shares after
141,091
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1, F5
RVMD transaction

Common Stock

Sale

Transaction value
-$148,029
Shares
-800
Change %
-0.57%
Price
$185.04
Shares after
140,291
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1, F6
RVMD transaction

Common Stock

Sale

Transaction value
-$74,566
Shares
-400
Change %
-0.29%
Price
$186.41
Shares after
139,891
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1, F7
RVMD transaction

Common Stock

Sale

Transaction value
-$112,402
Shares
-600
Change %
-0.43%
Price
$187.34
Shares after
139,291
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1, F8
RVMD transaction

Common Stock

Sale

Transaction value
-$37,834
Shares
-200
Change %
-0.14%
Price
$189.17
Shares after
139,091
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1
RVMD transaction

Common Stock

Sale

Transaction value
-$95,497
Shares
-500
Change %
-0.36%
Price
$190.99
Shares after
138,591
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1, F9
RVMD transaction

Common Stock

Sale

Transaction value
-$1,820,744
Shares
-9,486
Change %
-6.8%
Price
$191.94
Shares after
129,105
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1, F10
RVMD transaction

Common Stock

Sale

Transaction value
-$1,907,001
Shares
-9,889
Change %
-7.7%
Price
$192.84
Shares after
119,216
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1, F11, F12

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RVMD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-15,900
Change %
-100%
Price
$42.45*
Shares after
0
Date
11 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,900
Exercise price
$42.45
Footnotes
F1, F13
RVMD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-19,850
Change %
-96%
Price
$18.56*
Shares after
750
Date
11 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
19,850
Exercise price
$18.56
Footnotes
F1, F13
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 13 footnotes

Footnote F1

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 12, 2026.

Footnote F2

The transaction was executed in multiple trades at prices ranging from $180.50 to $181.45, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F3

The transaction was executed in multiple trades at prices ranging from $181.51 to $182.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F4

The transaction was executed in multiple trades at prices ranging from $182.56 to $183.51, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F5

The transaction was executed in multiple trades at prices ranging from $183.59 to $184.56, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F6

The transaction was executed in multiple trades at prices ranging from $184.59 to $185.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F7

The transaction was executed in multiple trades at prices ranging from $185.96 to $186.68, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F8

The transaction was executed in multiple trades at prices ranging from $186.99 to $187.62, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F9

The transaction was executed in multiple trades at prices ranging from $190.43 to $191.34, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F10

The transaction was executed in multiple trades at prices ranging from $191.44 to $192.43, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F11

The transaction was executed in multiple trades at prices ranging from $192.44 to $193.37, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F12

Includes 43,650 restricted stock units.

Footnote F13

Fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .